CorMedix Inc [NASDAQ: CRMD] jumped around 2.37 points on Tuesday, while shares priced at $10.30 at the close of the session, up 29.89%.
Compared to the average trading volume of 1.15M shares, CRMD reached a trading volume of 5633229 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about CorMedix Inc [CRMD]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CRMD shares is $17.20 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CRMD stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Rodman & Renshaw have made an estimate for CorMedix Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on August 26, 2024. While these analysts kept the previous recommendation, RBC Capital Mkts raised their target price to Outperform. The new note on the price target was released on August 10, 2023, representing the official price target for CorMedix Inc stock. Previously, the target price had yet another raise to $31, while Needham analysts kept a Buy rating on CRMD stock.
The Average True Range (ATR) for CorMedix Inc is set at 0.65, with the Price to Sales ratio for CRMD stock in the period of the last 12 months amounting to 50.98. The Price to Book ratio for the last quarter was 10.16, with the Price to Cash per share for the same quarter was set at 0.76.
How has CRMD stock performed recently?
CorMedix Inc [CRMD] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 27.16. With this latest performance, CRMD shares gained by 6.19% in over the last four-week period, additionally plugging by 139.53% over the last 6 months – not to mention a rise of 203.83% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CRMD stock in for the last two-week period is set at 63.70, with the RSI for the last a single of trading hit 72.48, and the three-weeks RSI is set at 58.79 for CorMedix Inc [CRMD]. The present Moving Average for the last 50 days of trading for this stock 9.83, while it was recorded at 8.55 for the last single week of trading, and 6.80 for the last 200 days.
CorMedix Inc [CRMD]: Deeper insight into the fundamentals
CorMedix Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.60 and a Current Ratio set at 3.96.
Insider trade positions for CorMedix Inc [CRMD]
There are presently around $31.93%, or 32.24%% of CRMD stock, in the hands of institutional investors. The top three institutional holders of CRMD stocks are: BLACKROCK INC. with ownership of 3.55 million shares, which is approximately 6.1796%. VANGUARD GROUP INC, holding 2.9 million shares of the stock with an approximate value of $$12.57 million in CRMD stocks shares; and VANGUARD GROUP INC, currently with $$6.71 million in CRMD stock with ownership which is approximately 2.6964%.
